Key Price Levels
Fundamentals
Deep Dive Analysis — Claude Sonnet
EQUIFAX (EFX) — MOMENTUM LEADER TRADE BRIEF
SETUP
EFX broke out hard today, opening at $184.34 and pushing to $194.80 — a clean gap-and-go structure. Price is holding above the breakout level near $192, with MACD freshly crossing bullish on the daily. The stock has outperformed SPY by 13.34% over the past 63 days, signaling sustained institutional accumulation. However, the signal quality score of 50/100 flags that this is not an early-in-move entry — price is already extended from a deeper base, and the 52-week high of $271.84 means there is significant overhead supply to work through. Risk/reward of 1:1.5 is acceptable but not exceptional.
CATALYSTS
EFX has beaten earnings estimates five consecutive quarters, with the most recent April 2025 beat coming in at plus 9% — the strongest in over a year. Mortgage and credit inquiry volumes are the core revenue driver; any Fed rate cut cycle or housing market reactivation would be a direct tailwind. The credit bureau sector broadly benefits from rising consumer credit activity and lending demand. The dividend narrative adds a modest income angle attracting longer-duration holders.
RISKS
EFX sits 29% below its 52-week high of $271.84 — that overhead supply is the single biggest technical headwind and limits upside momentum. Beta of 1.296 means this stock amplifies market drawdowns. The CEO insider activity shows large share disposals in July 2026 totaling over $10.7 million combined — that is a meaningful red flag at current price levels. Next earnings are not until October 2026, removing a near-term catalyst. A deterioration in mortgage activity or a credit tightening environment would directly compress top-line growth.
CONVICTION: Medium — The momentum and earnings track record are real, but the 50/100 signal score, heavy insider selling from the CEO, and substantial overhead resistance from the 52-week high keep conviction from reaching High.
Entry near $191-$192. Stop $180.76. TP1 $209.21, TP2 $220.60. Size accordingly given the elevated beta.